Seeing Is Believing
TherapeuticsMD's activity chart (see below) currently has 96 price targets and 102 ratings on display.
Analysts average stock forecasts to be materialized ratio is 10.32% with an average time for these price targets to be met of 92.67 days.
Most recent stock forecast was given by LOUISE CHEN from CANTOR FITZGERALD on 17-Aug-2023. First documented stock forecast 21-Sep-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 17-May-2022
$5
$3.2 (177.78%)
$5
3 years 2 months 15 days ago
(17-Aug-2023)
3/11 (27.27%)
$1.35 (36.99%)
631
Buy Since 17-Oct-2019
$125
4 years 4 months 25 days ago
(07-Jun-2022)
0/5 (0%)
$110.5 (762.07%)
Buy Since 10-Apr-2017
$450
5 years 2 months 27 days ago
(05-Aug-2021)
0/5 (0%)
$331 (278.15%)
Buy Since 10-Oct-2016
$250
$248.2 (13788.89%)
$300
5 years 5 months 26 days ago
(06-May-2021)
0/9 (0%)
$194.5 (350.45%)
Buy Since 04-Apr-2016
$450
5 years 6 months 25 days ago
(07-Apr-2021)
0/15 (0%)
$310 (221.43%)
What is TXMD (TherapeuticsMD) average time for price targets to be met?
Which analyst most recently updated their price target on TXMD (TherapeuticsMD)?
Which analyst has the most public recommendations on TXMD (TherapeuticsMD)?
Which analyst is the currently most bullish on TXMD (TherapeuticsMD)?
Which analyst is the currently most reserved on TXMD (TherapeuticsMD)?